Forte Biosciences amends 2021 equity incentive plan effective April 28, 2026.

Forte Biosciences adopted an amended and restated 2021 equity incentive plan to provide equity awards to employees, directors, and consultants. The plan update may impact future compensation structures and shareholder dilution for the bioscience company.